Strategies for Delivery of siRNAs to Ovarian Cancer Cells
The unmet need for novel therapeutic options for ovarian cancer (OC) deserves further investigation. Among the different novel drugs, small interfering RNAs (siRNAs) are particularly attractive because of their specificity of action and efficacy, as documented in many experimental setups. However, t...
Saved in:
Main Authors: | Rossella Farra (Author), Matea Maruna (Author), Francesca Perrone (Author), Mario Grassi (Author), Fabio Benedetti (Author), Marianna Maddaloni (Author), Maguie El Boustani (Author), Salvo Parisi (Author), Flavio Rizzolio (Author), Giancarlo Forte (Author), Fabrizio Zanconati (Author), Maja Cemazar (Author), Urska Kamensek (Author), Barbara Dapas (Author), Gabriele Grassi (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Overview of siRNA Delivery Strategies for Urological Cancers
by: Nadia Halib, et al.
Published: (2022) -
Xenograft Zebrafish Models for the Development of Novel Anti-Hepatocellular Carcinoma Molecules
by: Federica Tonon, et al.
Published: (2021) -
Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches
by: Tanja Jesenko, et al.
Published: (2023) -
In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells
by: Marianna Maddaloni, et al.
Published: (2024) -
A Guide to PIN1 Function and Mutations Across Cancers
by: Maguie El Boustani, et al.
Published: (2019)